Retour

Vaxcyte Announces Pricing of $1.3 Billion Public Offering

News Vaxcyte

Vaxcyte, a vaccine innovation company, announced the pricing of a $1.3 billion public offering of common stock and pre-funded warrants. The offering is expected to close on September 6, 2024.

GlobeNewswire Inc. • 05/09/2024 à 05:58:00
Vaxcyte, Inc. Common Stock
Adresse: 825 INDUSTRIAL ROAD, STE. 300
Code postal: 94070
Ville: SAN CARLOS
Region: CA
Numéro de telephone: 650-837-0111
Site internet: https://www.vaxcyte.com
Status: Active
Info de l'entreprise

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.

Date de référencement2020-06-12
MarchéStocks
LocaleUS
Echange principalXNAS
TypeCS
DeviseUSD
CIK0001649094
Composite figiBBG009PHHPL8
Share Class figiBBG009PHHPP4
Market Cap12,462,985,898 USD
SIC Code2836
SIC DescriptionBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Total Employés254
Share Class Shares Outstanding111610000
Weighted Shares Outstanding111695518
Round Lot100
Date de mise à jour2024-09-07
Stats
5 derniers jours
6-09
5-09
4-09
3-09
30-08
Dernier
111
111.53
109.715
110.26
80.73
Variation
-0.48%
1.84%
-0.48%
36.58%
1.63%
Ouverture
111.53
109.513
110.247
80.73
79.432
Plus haut
115.218
113.495
118.038
118.838
80.738
Plus bas
115.048
113.24
117.127
116.997
80.731
Historique
PériodeVarPlus hautPlus bas
1 semaine
37.5%
118.838
113.24
1 mois
56.4%
73.61
73.59
3 mois
57.47%
72.22
69.9
6 mois
53.04%
74.19
58.1
1 an
122.04%
50.91
44.2
3 ans
326.43%
26.03
16.78
5 ans
433.65%
28.5945
15.51
10 ans
433.65%
28.5945
15.51
Actions
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-08 2023-08-08 2023-11-06 UNPUB
Assets 1,008,163,000 1,502,819,000 1,496,057,000 UNPUB
Current Assets 840,674,000 1,310,317,000 1,295,434,000 UNPUB
Current Liabilities 52,747,000 60,216,000 85,558,000 UNPUB
Equity 944,771,000 1,433,376,000 1,402,716,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 944,771,000 1,433,376,000 1,402,716,000 UNPUB
Liabilities 63,392,000 69,443,000 93,341,000 UNPUB
Liabilities And Equity 1,008,163,000 1,502,819,000 1,496,057,000 UNPUB
Noncurrent Assets 167,489,000 192,502,000 200,623,000 UNPUB
Noncurrent Liabilities 10,645,000 9,227,000 7,783,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-08 2023-08-08 2023-11-06 UNPUB
Exchange Gains/Losses 23,000 -78,000 1,051,000 UNPUB
Net Cash Flow -454,206,000 150,582,000 14,333,000 UNPUB
Net Cash Flow, Continuing -454,229,000 150,660,000 13,282,000 UNPUB
Net Cash Flow From Financing Activities 41,562,000 546,966,000 48,550,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 41,562,000 546,966,000 48,550,000 UNPUB
Net Cash Flow From Investing Activities -448,101,000 -333,564,000 22,280,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -448,101,000 -333,564,000 22,280,000 UNPUB
Net Cash Flow From Operating Activities -47,690,000 -62,742,000 -57,548,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -47,690,000 -62,742,000 -57,548,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-08 2023-08-08 2023-11-06 UNPUB
Comprehensive Income/Loss -60,054,000 -70,907,000 -92,433,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -60,054,000 -70,907,000 -92,433,000 UNPUB
Other Comprehensive Income/Loss 408,000 -70,907,000 -92,433,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-08 2023-08-08 2023-11-06 UNPUB
Basic Earnings Per Share -1 -1 -1 UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share -1 -1 -1 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -60,462,000 -68,339,000 -92,664,000 UNPUB
Income/Loss From Continuing Operations Before Tax -60,462,000 -68,339,000 -92,664,000 UNPUB
Income Tax Expense/Benefit 0 0 0 UNPUB
Interest Expense, Operating UNPUB 0 0 UNPUB
Net Income/Loss -60,462,000 -68,339,000 -92,664,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -60,462,000 -68,339,000 -92,664,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -60,462,000 -68,339,000 92,664,000 UNPUB
Operating Expenses 71,192,000 87,147,000 113,026,000 UNPUB
Operating Income/Loss -71,192,000 -87,147,000 -113,026,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 -185,328,000 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 -185,328,000 UNPUB
Revenues 0 0 0 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-08-08 2022-11-07 2023-02-27
Assets 402,717,000 411,619,000 412,065,000 1,006,178,000
Current Assets 342,223,000 363,725,000 369,759,000 942,555,000
Current Liabilities 27,249,000 30,467,000 39,309,000 40,525,000
Equity 359,543,000 366,500,000 359,311,000 953,613,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 359,543,000 366,500,000 359,311,000 953,613,000
Liabilities 43,174,000 45,119,000 52,754,000 52,565,000
Liabilities And Equity 402,717,000 411,619,000 412,065,000 1,006,178,000
Noncurrent Assets 60,494,000 47,894,000 42,306,000 63,623,000
Noncurrent Liabilities 0 0 13,445,000 12,040,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-08-08 2022-11-07 2023-02-27
Exchange Gains/Losses -227,000 -485,000 53,000 137,000
Net Cash Flow 132,756,000 36,432,000 40,228,000 765,672,000
Net Cash Flow, Continuing 132,983,000 36,917,000 40,175,000 765,535,000
Net Cash Flow From Financing Activities 111,019,000 49,878,000 44,017,000 861,547,000
Net Cash Flow From Financing Activities, Continuing 111,019,000 49,878,000 44,017,000 861,547,000
Net Cash Flow From Investing Activities 49,666,000 26,165,000 34,706,000 74,585,000
Net Cash Flow From Investing Activities, Continuing 49,666,000 26,165,000 34,706,000 74,585,000
Net Cash Flow From Operating Activities -27,702,000 -39,126,000 -38,548,000 -170,597,000
Net Cash Flow From Operating Activities, Continuing -27,702,000 -39,126,000 -38,548,000 -170,597,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-08-08 2022-11-07 2023-02-27
Comprehensive Income/Loss -38,986,000 -48,532,000 -57,670,000 -223,605,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -39,578,000 -48,603,000 -57,670,000 -223,605,000
Other Comprehensive Income/Loss 0 0 -57,670,000 -120,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-08-08 2022-11-07 2023-02-27
Basic Earnings Per Share -1 -1 -1 -3
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share -1 -1 -1 -3
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -38,986,000 -48,532,000 -57,917,000 -223,485,000
Income/Loss From Continuing Operations Before Tax -38,986,000 -48,532,000 -57,917,000 -223,485,000
Income Tax Expense/Benefit 0 0 0 UNPUB
Interest Expense, Operating 0 2,000 0 2,000
Net Income/Loss -38,986,000 -48,532,000 -57,917,000 -223,485,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -38,986,000 -48,532,000 -57,917,000 -223,485,000
Net Income/Loss Available To Common Stockholders, Basic -38,986,000 -48,532,000 -57,917,000 -223,485,000
Operating Expenses 39,221,000 47,886,000 58,577,000 232,256,000
Operating Income/Loss -39,221,000 -47,886,000 -58,577,000 -232,256,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-11 2021-08-11 2021-11-10 2022-02-28
Assets 382,351,000 358,054,000 354,068,000 324,337,000
Current Assets 324,714,000 301,532,000 302,949,000 256,348,000
Current Liabilities 55,016,000 40,704,000 47,461,000 28,716,000
Equity 326,937,000 317,025,000 305,956,000 284,018,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 326,937,000 317,025,000 305,956,000 284,018,000
Liabilities 55,414,000 41,029,000 48,112,000 40,319,000
Liabilities And Equity 382,351,000 358,054,000 354,068,000 324,337,000
Noncurrent Assets 57,637,000 56,522,000 51,119,000 67,989,000
Noncurrent Liabilities 0 0 651,000 11,603,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-11 2021-08-11 2021-11-10 2022-02-28
Exchange Gains/Losses -281,000 311,000 333,000 -439,000
Net Cash Flow -186,390,000 -47,943,000 -38,952,000 -316,344,000
Net Cash Flow, Continuing -186,109,000 -48,254,000 -39,285,000 -315,905,000
Net Cash Flow From Financing Activities 487,000 956,000 7,599,000 17,796,000
Net Cash Flow From Financing Activities, Continuing 487,000 956,000 7,599,000 17,796,000
Net Cash Flow From Investing Activities -173,391,000 -20,530,000 -18,469,000 -212,308,000
Net Cash Flow From Investing Activities, Continuing -173,391,000 -20,530,000 -18,469,000 -212,308,000
Net Cash Flow From Operating Activities -13,205,000 -28,680,000 -28,415,000 -121,393,000
Net Cash Flow From Operating Activities, Continuing -13,205,000 -28,680,000 -28,415,000 -121,393,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-11 2021-08-11 2021-11-10 2022-02-28
Comprehensive Income/Loss -21,220,000 -23,679,000 -26,619,000 -100,318,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -21,267,000 -23,640,000 -26,619,000 -100,318,000
Other Comprehensive Income/Loss 0 0 -26,619,000 -241,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-11 2021-08-11 2021-11-10 2022-02-28
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -21,220,000 -23,679,000 -26,615,000 -100,077,000
Income/Loss From Continuing Operations Before Tax -21,220,000 -23,679,000 -26,615,000 -100,077,000
Income Tax Expense/Benefit 0 0 0 UNPUB
Interest Expense, Operating 0 7,000 0 7,000
Net Income/Loss -21,220,000 -23,679,000 -26,615,000 -100,077,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -21,220,000 -23,679,000 -26,615,000 -100,077,000
Net Income/Loss Available To Common Stockholders, Basic -21,220,000 -23,679,000 -26,615,000 -100,077,000
Operating Expenses 23,143,000 23,730,000 26,951,000 103,670,000
Operating Income/Loss -23,143,000 -23,730,000 -26,951,000 -103,670,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-12 2020-11-12 2021-03-29
Assets UNPUB 416,248,000 403,816,000 392,826,000
Current Assets UNPUB 413,057,000 400,835,000 389,004,000
Current Liabilities UNPUB 32,894,000 39,612,000 46,861,000
Equity UNPUB 383,210,000 364,075,000 345,843,000
Equity Attributable To Noncontrolling Interest UNPUB 0 0 0
Equity Attributable To Parent UNPUB 383,210,000 364,075,000 345,843,000
Liabilities UNPUB 33,038,000 39,741,000 46,983,000
Liabilities And Equity UNPUB 416,248,000 403,816,000 392,826,000
Noncurrent Assets UNPUB 3,191,000 2,981,000 3,822,000
Noncurrent Liabilities UNPUB 0 129,000 122,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-12 2020-11-12 2021-03-29
Exchange Gains/Losses UNPUB UNPUB UNPUB 87,000
Net Cash Flow UNPUB UNPUB -12,998,000 327,224,000
Net Cash Flow, Continuing UNPUB UNPUB -12,998,000 327,137,000
Net Cash Flow From Financing Activities UNPUB UNPUB 36,000 374,870,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 36,000 374,870,000
Net Cash Flow From Investing Activities UNPUB UNPUB 21,000 -1,105,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB 21,000 -1,105,000
Net Cash Flow From Operating Activities UNPUB UNPUB -13,055,000 -46,628,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -13,055,000 -46,628,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-12 2020-11-12 2021-03-29
Comprehensive Income/Loss UNPUB -20,320,000 -21,018,000 -89,217,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB -20,320,000 -21,018,000 -89,217,000
Other Comprehensive Income/Loss UNPUB 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB 2020-08-12 2020-11-12 2021-03-29
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB -20,320,000 -21,018,000 -89,217,000
Income/Loss From Continuing Operations Before Tax UNPUB -20,320,000 -21,018,000 -89,217,000
Income Tax Expense/Benefit UNPUB 0 0 UNPUB
Interest Expense, Operating UNPUB UNPUB 0 7,000
Net Income/Loss UNPUB -20,320,000 -21,018,000 -89,217,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB 0 0 0
Net Income/Loss Attributable To Parent UNPUB -20,320,000 -21,018,000 -89,217,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB -20,320,000 -21,018,000 -89,217,000
Operating Expenses UNPUB 21,224,000 21,308,000 89,581,000
Operating Income/Loss UNPUB -21,224,000 -21,308,000 -89,581,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB 0 0 0
Preferred Stock Dividends And Other Adjustments UNPUB 0 0 0
Revenues UNPUB 0 0 0
Calendrier économique
6 Septembre 2024 (heure UTC) Actuel Précédent Consensus
★
15:30
United States
SEP 03
-27700.000
-32700.000
★
15:30
United States
SEP 03
46100.000
52200.000
★
15:30
United States
SEP 03
-48800.000
-81900.000
★
15:30
United States
SEP 03
-100300.000
-92200.000
★★
15:30
United States
SEP 03
26000.000
21400.000
★
15:30
United States
SEP 03
287600.000
294400.000
★
15:30
United States
SEP 03
177000.000
226700.000
★
15:30
United States
SEP 03
-90500.000
-148500.000
★
15:30
United States
SEP 03
-162000.000
-184300.000
★
15:30
United States
SEP 03
13000.000
17100.000
★
15:30
United States
SEP 03
2300.000
2200.000
★
15:30
United States
★
15:30
United States
★★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:PCVX240719P00075000 OPASPS Put American 100 75 BATO 2024-07-19
O:PCVX240719P00070000 OPASPS Put American 100 70 BATO 2024-07-19
O:PCVX240719P00065000 OPASPS Put American 100 65 BATO 2024-07-19
O:PCVX240719P00060000 OPASPS Put American 100 60 BATO 2024-07-19
O:PCVX240719P00055000 OPASPS Put American 100 55 BATO 2024-07-19
O:PCVX240719P00050000 OPASPS Put American 100 50 BATO 2024-07-19
O:PCVX240719P00045000 OPASPS Put American 100 45 BATO 2024-07-19
O:PCVX240719P00040000 OPASPS Put American 100 40 BATO 2024-07-19
O:PCVX240719P00035000 OPASPS Put American 100 35 BATO 2024-07-19
O:PCVX240719P00030000 OPASPS Put American 100 30 BATO 2024-07-19
O:PCVX240719P00025000 OPASPS Put American 100 25 BATO 2024-07-19
O:PCVX240719C00075000 OCASPS Call American 100 75 BATO 2024-07-19
O:PCVX240719C00070000 OCASPS Call American 100 70 BATO 2024-07-19
O:PCVX240719C00065000 OCASPS Call American 100 65 BATO 2024-07-19
O:PCVX240719C00060000 OCASPS Call American 100 60 BATO 2024-07-19
O:PCVX240719C00055000 OCASPS Call American 100 55 BATO 2024-07-19
O:PCVX240719C00050000 OCASPS Call American 100 50 BATO 2024-07-19
O:PCVX240719C00045000 OCASPS Call American 100 45 BATO 2024-07-19
O:PCVX240719C00040000 OCASPS Call American 100 40 BATO 2024-07-19
O:PCVX240719C00035000 OCASPS Call American 100 35 BATO 2024-07-19
O:PCVX240719C00030000 OCASPS Call American 100 30 BATO 2024-07-19
O:PCVX240719C00025000 OCASPS Call American 100 25 BATO 2024-07-19
O:PCVX240719P00090000 OPASPS Put American 100 90 BATO 2024-07-19
O:PCVX240719P00085000 OPASPS Put American 100 85 BATO 2024-07-19
O:PCVX240719P00080000 OPASPS Put American 100 80 BATO 2024-07-19
O:PCVX240719C00090000 OCASPS Call American 100 90 BATO 2024-07-19
O:PCVX240719C00085000 OCASPS Call American 100 85 BATO 2024-07-19
O:PCVX240719C00080000 OCASPS Call American 100 80 BATO 2024-07-19
O:PCVX240719P00115000 OPASPS Put American 100 115 BATO 2024-07-19
O:PCVX240719P00110000 OPASPS Put American 100 110 BATO 2024-07-19
O:PCVX240719P00105000 OPASPS Put American 100 105 BATO 2024-07-19
O:PCVX240719P00100000 OPASPS Put American 100 100 BATO 2024-07-19
O:PCVX240719P00095000 OPASPS Put American 100 95 BATO 2024-07-19
O:PCVX240719C00115000 OCASPS Call American 100 115 BATO 2024-07-19
O:PCVX240719C00110000 OCASPS Call American 100 110 BATO 2024-07-19
O:PCVX240719C00105000 OCASPS Call American 100 105 BATO 2024-07-19
O:PCVX240719C00100000 OCASPS Call American 100 100 BATO 2024-07-19
O:PCVX240719C00095000 OCASPS Call American 100 95 BATO 2024-07-19
O:PCVX240621P00090000 OPASPS Put American 100 90 BATO 2024-06-21
O:PCVX240621P00085000 OPASPS Put American 100 85 BATO 2024-06-21
O:PCVX240621P00080000 OPASPS Put American 100 80 BATO 2024-06-21
O:PCVX240621P00075000 OPASPS Put American 100 75 BATO 2024-06-21
O:PCVX240621P00070000 OPASPS Put American 100 70 BATO 2024-06-21
O:PCVX240621P00065000 OPASPS Put American 100 65 BATO 2024-06-21
O:PCVX240621P00060000 OPASPS Put American 100 60 BATO 2024-06-21
O:PCVX240621P00055000 OPASPS Put American 100 55 BATO 2024-06-21
O:PCVX240621P00050000 OPASPS Put American 100 50 BATO 2024-06-21
O:PCVX240621P00045000 OPASPS Put American 100 45 BATO 2024-06-21
O:PCVX240621P00040000 OPASPS Put American 100 40 BATO 2024-06-21
O:PCVX240621P00035000 OPASPS Put American 100 35 BATO 2024-06-21
O:PCVX240621C00090000 OCASPS Call American 100 90 BATO 2024-06-21
O:PCVX240621C00085000 OCASPS Call American 100 85 BATO 2024-06-21
O:PCVX240621C00080000 OCASPS Call American 100 80 BATO 2024-06-21
O:PCVX240621C00075000 OCASPS Call American 100 75 BATO 2024-06-21
O:PCVX240621C00070000 OCASPS Call American 100 70 BATO 2024-06-21
O:PCVX240621C00065000 OCASPS Call American 100 65 BATO 2024-06-21
O:PCVX240621C00060000 OCASPS Call American 100 60 BATO 2024-06-21
O:PCVX240621C00055000 OCASPS Call American 100 55 BATO 2024-06-21
O:PCVX240621C00050000 OCASPS Call American 100 50 BATO 2024-06-21
O:PCVX240621C00045000 OCASPS Call American 100 45 BATO 2024-06-21
O:PCVX240621C00040000 OCASPS Call American 100 40 BATO 2024-06-21
O:PCVX240621C00035000 OCASPS Call American 100 35 BATO 2024-06-21
O:PCVX240517P00105000 OPASPS Put American 100 105 BATO 2024-05-17
O:PCVX240517P00100000 OPASPS Put American 100 100 BATO 2024-05-17
O:PCVX240517P00095000 OPASPS Put American 100 95 BATO 2024-05-17
O:PCVX240517P00090000 OPASPS Put American 100 90 BATO 2024-05-17
O:PCVX240517P00085000 OPASPS Put American 100 85 BATO 2024-05-17
O:PCVX240517P00080000 OPASPS Put American 100 80 BATO 2024-05-17
O:PCVX240517P00075000 OPASPS Put American 100 75 BATO 2024-05-17
O:PCVX240517P00070000 OPASPS Put American 100 70 BATO 2024-05-17
O:PCVX240517P00065000 OPASPS Put American 100 65 BATO 2024-05-17
O:PCVX240517P00060000 OPASPS Put American 100 60 BATO 2024-05-17
O:PCVX240517P00055000 OPASPS Put American 100 55 BATO 2024-05-17
O:PCVX240517P00050000 OPASPS Put American 100 50 BATO 2024-05-17
O:PCVX240517P00045000 OPASPS Put American 100 45 BATO 2024-05-17
O:PCVX240517P00040000 OPASPS Put American 100 40 BATO 2024-05-17
O:PCVX240517P00035000 OPASPS Put American 100 35 BATO 2024-05-17
O:PCVX240517C00105000 OCASPS Call American 100 105 BATO 2024-05-17
O:PCVX240517C00100000 OCASPS Call American 100 100 BATO 2024-05-17
O:PCVX240517C00095000 OCASPS Call American 100 95 BATO 2024-05-17
O:PCVX240517C00090000 OCASPS Call American 100 90 BATO 2024-05-17
O:PCVX240517C00085000 OCASPS Call American 100 85 BATO 2024-05-17
O:PCVX240517C00080000 OCASPS Call American 100 80 BATO 2024-05-17
O:PCVX240517C00075000 OCASPS Call American 100 75 BATO 2024-05-17
O:PCVX240517C00070000 OCASPS Call American 100 70 BATO 2024-05-17
O:PCVX240517C00065000 OCASPS Call American 100 65 BATO 2024-05-17
O:PCVX240517C00060000 OCASPS Call American 100 60 BATO 2024-05-17
O:PCVX240517C00055000 OCASPS Call American 100 55 BATO 2024-05-17
O:PCVX240517C00050000 OCASPS Call American 100 50 BATO 2024-05-17
O:PCVX240517C00045000 OCASPS Call American 100 45 BATO 2024-05-17
O:PCVX240517C00040000 OCASPS Call American 100 40 BATO 2024-05-17
O:PCVX240517C00035000 OCASPS Call American 100 35 BATO 2024-05-17
O:PCVX240419P00110000 OPASPS Put American 100 110 BATO 2024-04-19
O:PCVX240419P00105000 OPASPS Put American 100 105 BATO 2024-04-19
O:PCVX240419C00110000 OCASPS Call American 100 110 BATO 2024-04-19
O:PCVX240419C00105000 OCASPS Call American 100 105 BATO 2024-04-19
O:PCVX240419P00022500 OPASPS Put American 100 22.5 BATO 2024-04-19
O:PCVX240419C00022500 OCASPS Call American 100 22.5 BATO 2024-04-19
O:PCVX240419P00070000 OPASPS Put American 100 70 BATO 2024-04-19
O:PCVX240419P00065000 OPASPS Put American 100 65 BATO 2024-04-19
O:PCVX240419P00060000 OPASPS Put American 100 60 BATO 2024-04-19
O:PCVX240419P00055000 OPASPS Put American 100 55 BATO 2024-04-19
O:PCVX240419P00050000 OPASPS Put American 100 50 BATO 2024-04-19
O:PCVX240419P00045000 OPASPS Put American 100 45 BATO 2024-04-19
O:PCVX240419P00040000 OPASPS Put American 100 40 BATO 2024-04-19
O:PCVX240419P00035000 OPASPS Put American 100 35 BATO 2024-04-19
O:PCVX240419P00030000 OPASPS Put American 100 30 BATO 2024-04-19
O:PCVX240419P00025000 OPASPS Put American 100 25 BATO 2024-04-19
O:PCVX240419C00070000 OCASPS Call American 100 70 BATO 2024-04-19
O:PCVX240419C00065000 OCASPS Call American 100 65 BATO 2024-04-19
O:PCVX240419C00060000 OCASPS Call American 100 60 BATO 2024-04-19
O:PCVX240419C00055000 OCASPS Call American 100 55 BATO 2024-04-19
O:PCVX240419C00050000 OCASPS Call American 100 50 BATO 2024-04-19
O:PCVX240419C00045000 OCASPS Call American 100 45 BATO 2024-04-19
O:PCVX240419C00040000 OCASPS Call American 100 40 BATO 2024-04-19
O:PCVX240419C00035000 OCASPS Call American 100 35 BATO 2024-04-19
O:PCVX240419C00030000 OCASPS Call American 100 30 BATO 2024-04-19
O:PCVX240419C00025000 OCASPS Call American 100 25 BATO 2024-04-19
O:PCVX240419P00100000 OPASPS Put American 100 100 BATO 2024-04-19
O:PCVX240419P00095000 OPASPS Put American 100 95 BATO 2024-04-19
O:PCVX240419P00090000 OPASPS Put American 100 90 BATO 2024-04-19
O:PCVX240419P00085000 OPASPS Put American 100 85 BATO 2024-04-19
O:PCVX240419P00080000 OPASPS Put American 100 80 BATO 2024-04-19
O:PCVX240419P00075000 OPASPS Put American 100 75 BATO 2024-04-19
O:PCVX240419C00100000 OCASPS Call American 100 100 BATO 2024-04-19
O:PCVX240419C00095000 OCASPS Call American 100 95 BATO 2024-04-19
O:PCVX240419C00090000 OCASPS Call American 100 90 BATO 2024-04-19
O:PCVX240419C00085000 OCASPS Call American 100 85 BATO 2024-04-19
O:PCVX240419C00080000 OCASPS Call American 100 80 BATO 2024-04-19
O:PCVX240419C00075000 OCASPS Call American 100 75 BATO 2024-04-19
O:PCVX240419P00115000 OPASPS Put American 100 115 BATO 2024-04-19
O:PCVX240419C00115000 OCASPS Call American 100 115 BATO 2024-04-19
O:PCVX240315P00090000 OPASPS Put American 100 90 BATO 2024-03-15
O:PCVX240315P00085000 OPASPS Put American 100 85 BATO 2024-03-15
O:PCVX240315P00080000 OPASPS Put American 100 80 BATO 2024-03-15
O:PCVX240315P00075000 OPASPS Put American 100 75 BATO 2024-03-15
O:PCVX240315P00070000 OPASPS Put American 100 70 BATO 2024-03-15
O:PCVX240315P00065000 OPASPS Put American 100 65 BATO 2024-03-15
O:PCVX240315P00060000 OPASPS Put American 100 60 BATO 2024-03-15
O:PCVX240315P00055000 OPASPS Put American 100 55 BATO 2024-03-15
O:PCVX240315P00050000 OPASPS Put American 100 50 BATO 2024-03-15
O:PCVX240315P00045000 OPASPS Put American 100 45 BATO 2024-03-15
O:PCVX240315P00040000 OPASPS Put American 100 40 BATO 2024-03-15
O:PCVX240315P00035000 OPASPS Put American 100 35 BATO 2024-03-15
O:PCVX240315P00030000 OPASPS Put American 100 30 BATO 2024-03-15
O:PCVX240315C00090000 OCASPS Call American 100 90 BATO 2024-03-15
O:PCVX240315C00085000 OCASPS Call American 100 85 BATO 2024-03-15
O:PCVX240315C00080000 OCASPS Call American 100 80 BATO 2024-03-15
O:PCVX240315C00075000 OCASPS Call American 100 75 BATO 2024-03-15
O:PCVX240315C00070000 OCASPS Call American 100 70 BATO 2024-03-15
O:PCVX240315C00065000 OCASPS Call American 100 65 BATO 2024-03-15
O:PCVX240315C00060000 OCASPS Call American 100 60 BATO 2024-03-15
O:PCVX240315C00055000 OCASPS Call American 100 55 BATO 2024-03-15
O:PCVX240315C00050000 OCASPS Call American 100 50 BATO 2024-03-15
O:PCVX240315C00045000 OCASPS Call American 100 45 BATO 2024-03-15
O:PCVX240315C00040000 OCASPS Call American 100 40 BATO 2024-03-15
O:PCVX240315C00035000 OCASPS Call American 100 35 BATO 2024-03-15
O:PCVX240315C00030000 OCASPS Call American 100 30 BATO 2024-03-15
O:PCVX240315P00115000 OPASPS Put American 100 115 BATO 2024-03-15
O:PCVX240315P00110000 OPASPS Put American 100 110 BATO 2024-03-15
O:PCVX240315P00105000 OPASPS Put American 100 105 BATO 2024-03-15
O:PCVX240315P00100000 OPASPS Put American 100 100 BATO 2024-03-15
O:PCVX240315C00115000 OCASPS Call American 100 115 BATO 2024-03-15
O:PCVX240315C00110000 OCASPS Call American 100 110 BATO 2024-03-15
O:PCVX240315C00105000 OCASPS Call American 100 105 BATO 2024-03-15
O:PCVX240315C00100000 OCASPS Call American 100 100 BATO 2024-03-15
O:PCVX240315P00095000 OPASPS Put American 100 95 BATO 2024-03-15
O:PCVX240315C00095000 OCASPS Call American 100 95 BATO 2024-03-15
O:PCVX240216P00090000 OPASPS Put American 100 90 BATO 2024-02-16
O:PCVX240216P00085000 OPASPS Put American 100 85 BATO 2024-02-16
O:PCVX240216P00080000 OPASPS Put American 100 80 BATO 2024-02-16
O:PCVX240216P00075000 OPASPS Put American 100 75 BATO 2024-02-16
O:PCVX240216P00070000 OPASPS Put American 100 70 BATO 2024-02-16
O:PCVX240216P00065000 OPASPS Put American 100 65 BATO 2024-02-16
O:PCVX240216P00060000 OPASPS Put American 100 60 BATO 2024-02-16
O:PCVX240216P00055000 OPASPS Put American 100 55 BATO 2024-02-16
O:PCVX240216P00050000 OPASPS Put American 100 50 BATO 2024-02-16
O:PCVX240216P00045000 OPASPS Put American 100 45 BATO 2024-02-16
O:PCVX240216P00040000 OPASPS Put American 100 40 BATO 2024-02-16
O:PCVX240216P00035000 OPASPS Put American 100 35 BATO 2024-02-16
O:PCVX240216P00030000 OPASPS Put American 100 30 BATO 2024-02-16
O:PCVX240216C00090000 OCASPS Call American 100 90 BATO 2024-02-16
O:PCVX240216C00085000 OCASPS Call American 100 85 BATO 2024-02-16
O:PCVX240216C00080000 OCASPS Call American 100 80 BATO 2024-02-16
O:PCVX240216C00075000 OCASPS Call American 100 75 BATO 2024-02-16
O:PCVX240216C00070000 OCASPS Call American 100 70 BATO 2024-02-16
O:PCVX240216C00065000 OCASPS Call American 100 65 BATO 2024-02-16
O:PCVX240216C00060000 OCASPS Call American 100 60 BATO 2024-02-16
O:PCVX240216C00055000 OCASPS Call American 100 55 BATO 2024-02-16
O:PCVX240216C00050000 OCASPS Call American 100 50 BATO 2024-02-16
O:PCVX240216C00045000 OCASPS Call American 100 45 BATO 2024-02-16
O:PCVX240216C00040000 OCASPS Call American 100 40 BATO 2024-02-16
O:PCVX240216C00035000 OCASPS Call American 100 35 BATO 2024-02-16
O:PCVX240216C00030000 OCASPS Call American 100 30 BATO 2024-02-16
O:PCVX240119P00075000 OPASPS Put American 100 75 BATO 2024-01-19
O:PCVX240119C00075000 OCASPS Call American 100 75 BATO 2024-01-19
O:PCVX240119P00070000 OPASPS Put American 100 70 BATO 2024-01-19
O:PCVX240119P00065000 OPASPS Put American 100 65 BATO 2024-01-19
O:PCVX240119P00060000 OPASPS Put American 100 60 BATO 2024-01-19
O:PCVX240119P00055000 OPASPS Put American 100 55 BATO 2024-01-19
O:PCVX240119P00050000 OPASPS Put American 100 50 BATO 2024-01-19
O:PCVX240119P00045000 OPASPS Put American 100 45 BATO 2024-01-19
O:PCVX240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:PCVX240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:PCVX240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:PCVX240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:PCVX240119C00070000 OCASPS Call American 100 70 BATO 2024-01-19
O:PCVX240119C00065000 OCASPS Call American 100 65 BATO 2024-01-19
O:PCVX240119C00060000 OCASPS Call American 100 60 BATO 2024-01-19
O:PCVX240119C00055000 OCASPS Call American 100 55 BATO 2024-01-19
O:PCVX240119C00050000 OCASPS Call American 100 50 BATO 2024-01-19
O:PCVX240119C00045000 OCASPS Call American 100 45 BATO 2024-01-19
O:PCVX240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:PCVX240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:PCVX240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:PCVX240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:PCVX240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:PCVX240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:PCVX231215P00070000 OPASPS Put American 100 70 BATO 2023-12-15
O:PCVX231215P00065000 OPASPS Put American 100 65 BATO 2023-12-15
O:PCVX231215P00060000 OPASPS Put American 100 60 BATO 2023-12-15
O:PCVX231215P00055000 OPASPS Put American 100 55 BATO 2023-12-15
O:PCVX231215P00050000 OPASPS Put American 100 50 BATO 2023-12-15
O:PCVX231215P00045000 OPASPS Put American 100 45 BATO 2023-12-15
O:PCVX231215P00040000 OPASPS Put American 100 40 BATO 2023-12-15
O:PCVX231215P00035000 OPASPS Put American 100 35 BATO 2023-12-15
O:PCVX231215P00030000 OPASPS Put American 100 30 BATO 2023-12-15
O:PCVX231215P00025000 OPASPS Put American 100 25 BATO 2023-12-15
O:PCVX231215C00070000 OCASPS Call American 100 70 BATO 2023-12-15
O:PCVX231215C00065000 OCASPS Call American 100 65 BATO 2023-12-15
O:PCVX231215C00060000 OCASPS Call American 100 60 BATO 2023-12-15
O:PCVX231215C00055000 OCASPS Call American 100 55 BATO 2023-12-15
O:PCVX231215C00050000 OCASPS Call American 100 50 BATO 2023-12-15
O:PCVX231215C00045000 OCASPS Call American 100 45 BATO 2023-12-15
O:PCVX231215C00040000 OCASPS Call American 100 40 BATO 2023-12-15
O:PCVX231215C00035000 OCASPS Call American 100 35 BATO 2023-12-15
O:PCVX231215C00030000 OCASPS Call American 100 30 BATO 2023-12-15
O:PCVX231215C00025000 OCASPS Call American 100 25 BATO 2023-12-15
O:PCVX231117P00065000 OPASPS Put American 100 65 BATO 2023-11-17
O:PCVX231117P00060000 OPASPS Put American 100 60 BATO 2023-11-17
O:PCVX231117P00055000 OPASPS Put American 100 55 BATO 2023-11-17
O:PCVX231117P00050000 OPASPS Put American 100 50 BATO 2023-11-17
O:PCVX231117P00045000 OPASPS Put American 100 45 BATO 2023-11-17
O:PCVX231117P00040000 OPASPS Put American 100 40 BATO 2023-11-17
O:PCVX231117P00035000 OPASPS Put American 100 35 BATO 2023-11-17
O:PCVX231117P00030000 OPASPS Put American 100 30 BATO 2023-11-17
O:PCVX231117C00080000 OCASPS Call American 100 80 BATO 2023-11-17
O:PCVX231117P00025000 OPASPS Put American 100 25 BATO 2023-11-17
O:PCVX231117C00075000 OCASPS Call American 100 75 BATO 2023-11-17
O:PCVX231117C00025000 OCASPS Call American 100 25 BATO 2023-11-17
O:PCVX231117C00070000 OCASPS Call American 100 70 BATO 2023-11-17
O:PCVX231117C00065000 OCASPS Call American 100 65 BATO 2023-11-17
O:PCVX231117C00060000 OCASPS Call American 100 60 BATO 2023-11-17
O:PCVX231117C00055000 OCASPS Call American 100 55 BATO 2023-11-17
O:PCVX231117C00050000 OCASPS Call American 100 50 BATO 2023-11-17
O:PCVX231117C00045000 OCASPS Call American 100 45 BATO 2023-11-17
O:PCVX231117C00040000 OCASPS Call American 100 40 BATO 2023-11-17
O:PCVX231117C00035000 OCASPS Call American 100 35 BATO 2023-11-17
O:PCVX231117C00030000 OCASPS Call American 100 30 BATO 2023-11-17
O:PCVX231117P00080000 OPASPS Put American 100 80 BATO 2023-11-17
O:PCVX231117P00075000 OPASPS Put American 100 75 BATO 2023-11-17
O:PCVX231117P00070000 OPASPS Put American 100 70 BATO 2023-11-17
O:PCVX231020P00075000 OPASPS Put American 100 75 BATO 2023-10-20
O:PCVX231020P00070000 OPASPS Put American 100 70 BATO 2023-10-20
O:PCVX231020P00065000 OPASPS Put American 100 65 BATO 2023-10-20
O:PCVX231020P00060000 OPASPS Put American 100 60 BATO 2023-10-20
O:PCVX231020P00055000 OPASPS Put American 100 55 BATO 2023-10-20
O:PCVX231020P00050000 OPASPS Put American 100 50 BATO 2023-10-20
O:PCVX231020P00045000 OPASPS Put American 100 45 BATO 2023-10-20
O:PCVX231020P00040000 OPASPS Put American 100 40 BATO 2023-10-20
O:PCVX231020P00035000 OPASPS Put American 100 35 BATO 2023-10-20
O:PCVX231020P00030000 OPASPS Put American 100 30 BATO 2023-10-20
O:PCVX231020P00025000 OPASPS Put American 100 25 BATO 2023-10-20
O:PCVX231020P00022500 OPASPS Put American 100 22.5 BATO 2023-10-20
O:PCVX231020P00020000 OPASPS Put American 100 20 BATO 2023-10-20
O:PCVX231020C00075000 OCASPS Call American 100 75 BATO 2023-10-20
O:PCVX231020C00070000 OCASPS Call American 100 70 BATO 2023-10-20
O:PCVX231020C00065000 OCASPS Call American 100 65 BATO 2023-10-20
O:PCVX231020C00060000 OCASPS Call American 100 60 BATO 2023-10-20
O:PCVX231020C00055000 OCASPS Call American 100 55 BATO 2023-10-20
O:PCVX231020C00050000 OCASPS Call American 100 50 BATO 2023-10-20
O:PCVX231020C00045000 OCASPS Call American 100 45 BATO 2023-10-20
O:PCVX231020C00040000 OCASPS Call American 100 40 BATO 2023-10-20
O:PCVX231020C00035000 OCASPS Call American 100 35 BATO 2023-10-20
O:PCVX231020C00030000 OCASPS Call American 100 30 BATO 2023-10-20
O:PCVX231020C00025000 OCASPS Call American 100 25 BATO 2023-10-20
O:PCVX231020C00022500 OCASPS Call American 100 22.5 BATO 2023-10-20
O:PCVX231020C00020000 OCASPS Call American 100 20 BATO 2023-10-20
O:PCVX230915P00070000 OPASPS Put American 100 70 BATO 2023-09-15
O:PCVX230915P00065000 OPASPS Put American 100 65 BATO 2023-09-15
O:PCVX230915P00060000 OPASPS Put American 100 60 BATO 2023-09-15
O:PCVX230915P00055000 OPASPS Put American 100 55 BATO 2023-09-15
O:PCVX230915P00050000 OPASPS Put American 100 50 BATO 2023-09-15
O:PCVX230915P00045000 OPASPS Put American 100 45 BATO 2023-09-15
O:PCVX230915P00040000 OPASPS Put American 100 40 BATO 2023-09-15
O:PCVX230915P00035000 OPASPS Put American 100 35 BATO 2023-09-15
O:PCVX230915P00030000 OPASPS Put American 100 30 BATO 2023-09-15
O:PCVX230915P00025000 OPASPS Put American 100 25 BATO 2023-09-15
O:PCVX230915C00070000 OCASPS Call American 100 70 BATO 2023-09-15
O:PCVX230915C00065000 OCASPS Call American 100 65 BATO 2023-09-15
O:PCVX230915C00060000 OCASPS Call American 100 60 BATO 2023-09-15
O:PCVX230915C00055000 OCASPS Call American 100 55 BATO 2023-09-15
O:PCVX230915C00050000 OCASPS Call American 100 50 BATO 2023-09-15
O:PCVX230915C00045000 OCASPS Call American 100 45 BATO 2023-09-15
O:PCVX230915C00040000 OCASPS Call American 100 40 BATO 2023-09-15
O:PCVX230915C00035000 OCASPS Call American 100 35 BATO 2023-09-15
O:PCVX230915C00030000 OCASPS Call American 100 30 BATO 2023-09-15
O:PCVX230915C00025000 OCASPS Call American 100 25 BATO 2023-09-15
O:PCVX230818P00075000 OPASPS Put American 100 75 BATO 2023-08-18
O:PCVX230818P00070000 OPASPS Put American 100 70 BATO 2023-08-18
O:PCVX230818P00065000 OPASPS Put American 100 65 BATO 2023-08-18
O:PCVX230818P00060000 OPASPS Put American 100 60 BATO 2023-08-18
O:PCVX230818P00055000 OPASPS Put American 100 55 BATO 2023-08-18
O:PCVX230818P00050000 OPASPS Put American 100 50 BATO 2023-08-18
O:PCVX230818P00045000 OPASPS Put American 100 45 BATO 2023-08-18
O:PCVX230818P00040000 OPASPS Put American 100 40 BATO 2023-08-18
O:PCVX230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:PCVX230818P00030000 OPASPS Put American 100 30 BATO 2023-08-18
O:PCVX230818C00075000 OCASPS Call American 100 75 BATO 2023-08-18
O:PCVX230818C00070000 OCASPS Call American 100 70 BATO 2023-08-18
O:PCVX230818C00065000 OCASPS Call American 100 65 BATO 2023-08-18
O:PCVX230818C00060000 OCASPS Call American 100 60 BATO 2023-08-18
O:PCVX230818C00055000 OCASPS Call American 100 55 BATO 2023-08-18
O:PCVX230818C00050000 OCASPS Call American 100 50 BATO 2023-08-18
O:PCVX230818C00045000 OCASPS Call American 100 45 BATO 2023-08-18
O:PCVX230818C00040000 OCASPS Call American 100 40 BATO 2023-08-18
O:PCVX230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
O:PCVX230818C00030000 OCASPS Call American 100 30 BATO 2023-08-18
Flux d'actualités
News Vaxcyte
Vaxcyte Announces Pricing of $1.3 Billion Public Offering
Vaxcyte, a vaccine innovation company, announced the pricing of a $1.3 billion public offering of common stock and pre-funded warrants. The offering is expected to close on September 6, 2024.
GlobeNewswire Inc. • Il y a 3 jours
News Vaxcyte
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Vaxcyte, a vaccine innovation company, has announced a $1.0 billion public offering of its common stock and pre-funded warrants. The offering is subject to market conditions and will be used to fund the development of the company's vaccine candidates.
GlobeNewswire Inc. • Il y a 4 jours
News Vaxcyte
Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
Vaxcyte's 31-valent pneumococcal conjugate vaccine candidate, VAX-31, showed promising results in a Phase 1/2 study, meeting or exceeding the immunogenicity criteria compared to Pfizer's Prevnar 20. Vaxcyte plans to initiate a Phase 3 study by mid-2025.
Benzinga • Il y a 5 jours
News Vaxcyte
Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older
Vaxcyte, a vaccine innovation company, will present topline results from a Phase 1/2 study evaluating the safety, tolerability, and immunogenicity of its 31-valent pneumococcal conjugate vaccine candidate, VAX-31, in adults aged 50 and older.
GlobeNewswire Inc. • Il y a 5 jours
Management Directors and Officers
Vaxcyte Appoints John Furey to Board of Directors
Vaxcyte appoints John Furey to Board of Directors.
GlobeNewswire Inc. • Il y a 2 mois
Calendar Calendar of Events
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today that Company management will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9 at 12:45 p.m. ET / 9:45 a.m. PT.
GlobeNewswire Inc. • Il y a 5 mois
Health Health
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
-- Company Expects to Announce Topline Safety, Tolerability and Immunogenicity Data from Primary Immunization Series by the End of the First Quarter of 2025, Followed by Topline Data from Booster Dose by the End of 2025 -- -- VAX-24, a 24-Valent Pneumococcal Conjugate Vaccine (PCV), is Designed to Cover More Serotypes Than Any Infant Pneumococcal Vaccine On-Market or in U.S. Clinics Today --
GlobeNewswire Inc. • Il y a 6 mois
News News
Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know
Does Vaxcyte, Inc. (PCVX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research • Il y a 6 mois
Stocks Earnings Releases and Operating Results
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-- VAX-31 Adult Program Phase 1/2 Study Enrollment Complete; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 -- -- Completed Successful VAX-24 Phase 2 Adult Program and End-of-Phase 2 Meeting; VAX-24 is Phase 3-Ready in Adults --
GlobeNewswire Inc. • Il y a 6 mois
News News
Why Vaxcyte (PCVX) Might Surprise This Earnings Season
Vaxcyte (PCVX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zacks Investment Research • Il y a 6 mois
Voir tous
Actualités liées
Dernières actualités

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT